Download PDF
1 / Pages

Other users also viewed these articles

Markers of cardiovascular risk and their reversibility with acute oxygen therapy in Kyrgyz highlanders with high altitude pulmonary hypertension M. Furian; T.D. Latshang; S.S. Aeschbacher; U. Sheraliev; N.H. Marazhapov; E. Mirrakhimov; S. Ulrich; T.M. Sooronbaev; K.E. Bloch;
Pulmonol. 2021;27:394-402
High altitudes and partial pressure of arterial oxygen in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis A. Sevik; T. Gaisl; A. Forrer; L. Graf; S. Ulrich; K.E. Bloch; M. Lichtblau; M. Furian;
10.1016/j.pulmoe.2024.06.002
Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial M. Lichtblau; S. Saxer; J. Müller; P. Appenzeller; C. Berlier; S.R. Schneider; L. Mayer; M. Furian; E.I. Schwarz; E.R. Swenson; K.E. Bloch; S. Ulrich;
Pulmonol. 2024;30:362-9